How effective are endoscopic gel injections in treating pediatric vesicoureteral reflux?
This article has no abstract so we have provided the first paragraph of the full text.
A US team has called for the endoscopic injection of nonanimal stabilized hyaluronic acid–dextranomer (NASHA–Dx; a nonimmunogenic, biodegradable gel that does not migrate from the injection site) to be adopted as a first-line treatment for children with grade II–IV vesicoureteral reflux.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.